Patients with loss-of-function CYP24A1 mutations have been successfully treated with inhibitors of vitamin D synthesis including fluconazole, similar therapies may be useful in rs17216707 (TT) recurrent kidney stone formers33. Here, CYP24A1 is linked to nephrolithiasis.